Welcome back to Stockhouse Member Sign In
Sign in with one of the following accounts.
Send my password
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Use one of the following accounts.
Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.
Everything you could ever want to know about biotech, biomed and bio investments up north.
HighGrowth wrote: I was about to dump my shares when Valeant said the "could pay a lot more" for it, but the reprieve from overpaying...
I was about to dump my shares when Valeant said the "could pay a lot more" for it, but the reprieve from overpaying for an acquisition...
It's up since they made several hundred million on the deal and elected to walk away rather than fight further and gain a pyrrhic victory...
how this can be up while actavis and allergan are merging. They were not able to eat allergan. the market will remenber. They growth...
call the emoigency